- Filed
- Apr 23, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 14, 2025 | 35.48M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $5.7M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $7.2M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $217.2M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $415.1M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.29B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.31B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $2.6B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $2.62B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.86B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.88B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $3.46B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $3.47B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 35.8M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $39.1M |
| Capex | Q1 2025 · Mar 31, 2024 | $29.5M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$22.8M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $368.8M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $285.3M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $3.47 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $3.49 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $170.7M |
| Net Income | Q1 2025 · Mar 31, 2024 | $124.3M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $166.8M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $340M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $707.1M |
| Revenue | Q1 2025 · Mar 31, 2024 | $1.05B |